CMN 552 EXAM 3 EXAM REVIEW QUESTIONS
AND CORRECT ANSWERS
◉ Naltrexone can be used for.
Answer: both ETOH and opioid use disorders
◉ What does naltrexone do.
Answer: Reduces desire/cravings, First line treatment, Will
precipitate withdrawal in patients with physical opioid dependence
◉ First line treatment in maintaining abstinence after detox.
Answer: acamprosate
◉ acamprosate can be used.
Answer: in liver disease- not metabolized by the liver (not impacted
by ETOH use). Can be administered to patients with hepatitis, liver
disease, and those who continue drinking alcohol
◉ acamprosate Contraindicated in.
Answer: severe renal disease
◉ acamprosate helps with.
,Answer: Decreasing cravings
◉ ETOH 2nd line treatment.
Answer: disulfiram (Antabuse)
◉ disulfiram (Antabuse) causes.
Answer: aversion reaction to ETOH (flushing, headaches, n/v,
palpitation, SOB, vertigo, hypotension)
◉ disulfiram (Antabuse) Do not.
Answer: administer until the person has been alcohol free at least 12
hours
◉ disulfiram (Antabuse) MOA.
Answer: Blocks enzyme (aldehyde dehydrogenase) in the liver
◉ ETOH withdrawal- Benzos.
Answer: To keep patient calm and lightly sedated
◉ Benzos MOA.
Answer: Enhance the effects of GABA
, ◉ Meds used in mild alcohol withdrawal.
Answer: Tegretol, Valproic or Gabapentin
◉ ETHO meds for nutritional deficiencies.
Answer: Thiamine, folic acid, and multivitamin - 'Banana bag'
◉ Wernicke's encephalopathy treatment.
Answer: Parenteral Thiamine and Folate
◉ Wernicke's encephalopathy cause.
Answer: B1 deficiency
◉ Cocaine mechanism.
Answer: reuptake of dopamine, epinephrine, and NE = Stimulant
effect
◉ Cocaine effects on the body.
Answer: has vasoconstrictive effects = can cause MI, stroke
◉ Cocaine treatment options.
Answer: NO FDA approved med; Off-label = naltrexone, modafinil,
Topamax
AND CORRECT ANSWERS
◉ Naltrexone can be used for.
Answer: both ETOH and opioid use disorders
◉ What does naltrexone do.
Answer: Reduces desire/cravings, First line treatment, Will
precipitate withdrawal in patients with physical opioid dependence
◉ First line treatment in maintaining abstinence after detox.
Answer: acamprosate
◉ acamprosate can be used.
Answer: in liver disease- not metabolized by the liver (not impacted
by ETOH use). Can be administered to patients with hepatitis, liver
disease, and those who continue drinking alcohol
◉ acamprosate Contraindicated in.
Answer: severe renal disease
◉ acamprosate helps with.
,Answer: Decreasing cravings
◉ ETOH 2nd line treatment.
Answer: disulfiram (Antabuse)
◉ disulfiram (Antabuse) causes.
Answer: aversion reaction to ETOH (flushing, headaches, n/v,
palpitation, SOB, vertigo, hypotension)
◉ disulfiram (Antabuse) Do not.
Answer: administer until the person has been alcohol free at least 12
hours
◉ disulfiram (Antabuse) MOA.
Answer: Blocks enzyme (aldehyde dehydrogenase) in the liver
◉ ETOH withdrawal- Benzos.
Answer: To keep patient calm and lightly sedated
◉ Benzos MOA.
Answer: Enhance the effects of GABA
, ◉ Meds used in mild alcohol withdrawal.
Answer: Tegretol, Valproic or Gabapentin
◉ ETHO meds for nutritional deficiencies.
Answer: Thiamine, folic acid, and multivitamin - 'Banana bag'
◉ Wernicke's encephalopathy treatment.
Answer: Parenteral Thiamine and Folate
◉ Wernicke's encephalopathy cause.
Answer: B1 deficiency
◉ Cocaine mechanism.
Answer: reuptake of dopamine, epinephrine, and NE = Stimulant
effect
◉ Cocaine effects on the body.
Answer: has vasoconstrictive effects = can cause MI, stroke
◉ Cocaine treatment options.
Answer: NO FDA approved med; Off-label = naltrexone, modafinil,
Topamax
